Diluted EPS came in at $-0.68, beat the $-0.75 consensus by $0.07.
Trailing eight quarters through Q3 2024
Common questions about Replimune Group's Q3 2024 earnings report.
Replimune Group (REPL) reported Q3 2024 earnings on November 12, 2024 before market open.
Replimune Group reported diluted EPS of $-0.68 for Q3 2024.
EPS beat the consensus estimate of $-0.75 by $0.07.
You can read the 10-Q periodic report (0001737953-24-000015) directly on SEC EDGAR. The filing index links above go to sec.gov.